Table 7. Second stage results for system (9’), Maximum Likelihood efficient method.
|
Dependent |
ML |
/V ML (predict k ) |
ML |
/V ML (predict k ) | |||||
|
K ∆7 ln — 2 L Lit |
Coeff |
Robust St. E. |
Coeff |
Robust Std. Err. |
Coeff |
Robust St. E. |
Coeff |
Robust St. E. | |
|
Innovative firms |
Non Innovative firms | ||||||||
|
αι |
.2588*** |
.0244 |
.1967*** |
.0382 |
α2 |
.0199 |
.0195 |
-.0004 |
.0252 |
|
21______ |
17.00*** |
3.343 |
18.17*** |
3.381 |
β2_______ |
-6.658 |
10.85 |
-6.414 |
10.023 |
|
Yi |
-.4028*** |
.056 |
-.3862*** |
.0591 |
Y2 |
-.0105 |
.1473 |
-.0051 |
.1462 |
|
μι |
-.1878*** |
.0288 |
-.2172*** |
.0308 |
μ2 |
-.242** |
.1174 |
-.2369** |
.1167 |
|
σι |
28.719*** |
.8895 |
30.51*** |
1.096 |
σ2 |
29.941*** |
.2622 |
29.93*** |
.1986 |
|
Pi |
.6917 |
.0936 |
.6421 |
.1211 |
P2 |
.1126 |
.1385 |
.1039 |
.1179 |
|
Mills ratio |
.4439** |
.2767 |
.444** |
.2821 |
1.364*** |
.5181 |
1.368*** |
.5282 | |
|
Condition |
Exogenous K |
Endogenous K | |||||||
|
Wald χ2(i) |
22.86 [0.000] |
13.95 | |||||||
|
P(Inno) |
.7356 |
.1785 |
.735 |
.1816 | |||||
|
N |
7773 |
7773 | |||||||
Note. All regressions include size, area and sector dummies. Columns 3 and 4 show ML with predicted value of the
growth rate of capital stock for innovative firms. Columns 7 and 8 replicate ML with predicted value for the non
innovative cluster. Wald Chi-square test is testing for the independence of the residuals in system (8). P(Inno) is the
predicted probability of being in the innovative regime in the first stage.
8. Conclusions
In this paper we exploited data from a sample of some eight thousands innovative and non-
innovative firm-observations to describe the pattern of correlation between experience, innovation
and productivity growth during the recent period of serious productivity slowdown in the Italian
24
More intriguing information
1. Human Rights Violations by the Executive: Complicity of the Judiciary in Cameroon?2. Short Term Memory May Be the Depletion of the Readily Releasable Pool of Presynaptic Neurotransmitter Vesicles
3. The name is absent
4. Evaluating the Impact of Health Programmes
5. CAN CREDIT DEFAULT SWAPS PREDICT FINANCIAL CRISES? EMPIRICAL STUDY ON EMERGING MARKETS
6. The Advantage of Cooperatives under Asymmetric Cost Information
7. Iconic memory or icon?
8. Improvements in medical care and technology and reductions in traffic-related fatalities in Great Britain
9. Quelles politiques de développement durable au Mali et à Madagascar ?
10. The name is absent